{"id":126049,"date":"2021-12-06T13:30:11","date_gmt":"2021-12-06T18:30:11","guid":{"rendered":"https:\/\/44.250.171.167\/?p=126049"},"modified":"2021-12-06T13:31:47","modified_gmt":"2021-12-06T18:31:47","slug":"infographic-how-cipla-performed-in-q2-2022","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/infographic-how-cipla-performed-in-q2-2022\/","title":{"rendered":"Infographic: How Cipla performed in Q2 2022"},"content":{"rendered":"\n<p>Cipla Limited<a href=\"https:\/\/44.250.171.167\/symbol\/cipla\/\">(NSE: CIPLA)<\/a> posted its second-quarter 2022 results.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"608\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222-608x1024.jpg\" alt=\"\" class=\"wp-image-126050\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222-608x1024.jpg 608w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222-178x300.jpg 178w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222-768x1294.jpg 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222-912x1536.jpg 912w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222-1216x2048.jpg 1216w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222.jpg 1280w\" sizes=\"auto, (max-width: 608px) 100vw, 608px\" \/><\/figure>\n\n\n\n<p>The company posted consolidated revenue of \u20b95,580 crores with a growth of 9% year on year.<\/p>\n\n\n\n<p>Cipla had a net profit of \u20b9709 crores or \u20b98.80 per share compared to \u20b9659 crores or \u20b98.24 per share in the same quarter of the previous year.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cipla Limited(NSE: CIPLA) posted its second-quarter 2022 results. The company posted consolidated revenue of \u20b95,580 crores with a growth of 9% year on year. Cipla had a net profit of \u20b9709 crores or \u20b98.80 per share compared to \u20b9659 crores or \u20b98.24 per share in the same quarter of the previous year.<\/p>\n","protected":false},"author":1738,"featured_media":126050,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[9138,1408,1115],"class_list":["post-126049","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-pharma","tag-pharma-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/12\/CiplaQ222.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":125206,"url":"https:\/\/alphastreet.com\/india\/how-did-cipla-perform-in-q2-2022\/","url_meta":{"origin":126049,"position":0},"title":"How Cipla performed in Q2 2022","author":"Nishadkishore","date":"October 26, 2021","format":false,"excerpt":"The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue increased by 10.3% to \u20b95,486 crores compared to \u20b94,972 crores in the previous year of the same quarter. The company had a total net profit of \u20b9711 crores or \u20b98.80\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":139207,"url":"https:\/\/alphastreet.com\/india\/infographic-cipla-ltd-nse-cipla-q3-fy23-results-total-income-falls-0-45-qoq\/","url_meta":{"origin":126049,"position":1},"title":"Infographic Cipla Ltd.(NSE: CIPLA) | Q3 FY23 Results | Total Income falls -0.45% qoq","author":"Divyansh_Kasana","date":"January 25, 2023","format":false,"excerpt":"Cipla Limited (NSE: CIPLA) is an Indian multinational pharmaceutical and biopharmaceutical company. Founded in 1935, Cipla primarily develops and sells generic and over-the-counter drugs, active pharmaceutical ingredients, and biopharmaceuticals. The company has operations in over 80 countries, with a focus on the developing world. Cipla is known for its affordable\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/91871a78-5c9c-4023-98bc-ced0a2b4bc5b.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/91871a78-5c9c-4023-98bc-ced0a2b4bc5b.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/91871a78-5c9c-4023-98bc-ced0a2b4bc5b.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/91871a78-5c9c-4023-98bc-ced0a2b4bc5b.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/91871a78-5c9c-4023-98bc-ced0a2b4bc5b.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/91871a78-5c9c-4023-98bc-ced0a2b4bc5b.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165582,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q2fy25-13-rise-in-profits\/","url_meta":{"origin":126049,"position":2},"title":"Cipla Ltd Q2FY25; 13% rise in Profits","author":"Divyansh_Kasana","date":"November 13, 2024","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q2FY25 of \u20b97,051.00 Crores up from \u20b96,678.00 Crore year on year, a rise of 5.59%. Total Expenses for Q2FY25 of \u20b95,452.00 Crores up from \u20b95,260.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/DT-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167458,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q3fy25-47-rise-in-profits\/","url_meta":{"origin":126049,"position":3},"title":"Cipla Ltd Q3FY25; 47% rise in Profits","author":"Divyansh_Kasana","date":"March 19, 2025","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q3FY25 of \u20b97,073.00 Crores up from \u20b96,604.00 Crore year on year, a rise of 7.1%. Total Expenses for Q3FY25 of \u20b95,379.00 Crores up from \u20b95,119.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/U-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168941,"url":"https:\/\/alphastreet.com\/india\/cipla-ltd-q4fy25-30-rise-in-profits-2\/","url_meta":{"origin":126049,"position":4},"title":"Cipla Ltd Q4FY25; 30% rise in Profits","author":"Divyansh_Kasana","date":"June 30, 2025","format":false,"excerpt":"Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q4FY25 of \u20b96,730.00 Crores up from \u20b96,163.00 Crore year on year, a rise of 9.2%. Total Expenses for Q4FY25 of \u20b95,515.00 Crores up from \u20b95,153.00 Crores year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-19.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":131066,"url":"https:\/\/alphastreet.com\/india\/cipla-q4-fy2022-research-summary\/","url_meta":{"origin":126049,"position":5},"title":"Cipla Q4 FY2022 Research Summary","author":"sreerupa","date":"July 11, 2022","format":false,"excerpt":"Cipla is an Indian multinational pharmaceutical company. The company was incorporated in the year 1935. The founder is Khwaja Abdul Hamied. Cipla has its headquarters in Mumbai. The company has extended its business worldwide.\u00a0 The presence of this company is marked in Australia, Europe, Kenya, Malaysia, Morocco, Nepal, South Africa,\u2026","rel":"","context":"In &quot;Research Summary&quot;","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"Research Summary","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/04\/Research-summary.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/04\/Research-summary.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/04\/Research-summary.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/126049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1738"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=126049"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/126049\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/126050"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=126049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=126049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=126049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}